Johnson & Johnson to Participate in the UBS Global Healthcare Conference
Rhea-AI Summary
Johnson & Johnson (NYSE: JNJ) will attend the UBS Global Healthcare Conference on May 24, 2022. Mathai Mammen, Executive Vice President of Pharmaceuticals R&D, will represent the company during a session at 10:00 a.m. ET. Interested investors can access the live webcast and subsequent replay, which will be available approximately 48 hours later, through the Johnson & Johnson website.
Positive
- None.
Negative
- None.
News Market Reaction – JNJ
On the day this news was published, JNJ declined 0.29%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
NEW BRUNSWICK, N.J., April 20, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24th. Mathai Mammen, Executive Vice President, Pharmaceuticals R&D, will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately 48 hours after the live webcast.
View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-ubs-global-healthcare-conference-301529498.html
SOURCE Johnson & Johnson
FAQ
When will Johnson & Johnson participate in the UBS Global Healthcare Conference?
Who will represent Johnson & Johnson at the UBS Global Healthcare Conference?
What time is Johnson & Johnson's session at the UBS Global Healthcare Conference?
How can I access the Johnson & Johnson webcast for the UBS Global Healthcare Conference?
Will there be a replay of Johnson & Johnson's webcast from the UBS Global Healthcare Conference?
